Fixing the ImpossiBle
24/7 (202) 973-1300   

Richard Levick in WSJ

Richard Levick was recently quoted in the Wall Street Journal on Mylan’s handling of the EpiPen crisis:

“It’s not good when a corporate crisis gets its own hashtag and thousands of people begin using it. It’s even worse when that hashtag ends in ‘gate.’ Yet Mylan’s handling of its EpiPen pricing issue#Epigate as it was tagged by one parent/activistis hardly scandalous. In truth, once it became a news story three days after #Epigate was coined, Mylan deserves reasonably high marks for its response. Its messaging and strategy were solid. It offered a discounted purchasing plan. It took the dramatic step of developing a generic alternative to make EpiPen more affordable. Its chief executive assumed public responsibility and made herself accessible to the media.”

More Posts

Your Very Bad Day

By Joe Stimac This week’s guest columnist is Joe Stimac, CEO of AccuHire and creator of Joe is a research scientist and a sought-after

The Golden Hours

First is a Series on Risk Preparation and Communications By Richard Levick “But in all my experience, I have never been in any accident… of